Oral bioavailability: issues and solutions via nanoformulations

K Pathak, S Raghuvanshi - Clinical pharmacokinetics, 2015 - Springer
The delivery of drugs through the oral route is regarded as most optimal to achieve desired
therapeutic effects and patient compliance. However, poor pharmacokinetic profiles of oral …
被引用次数：171 相关文章

Oral Bioavailability: Issues and Solutions via Nanoformulations

K Pathak, S Raghuvanshi - Clinical Pharmacokinetics, 2015 - search.proquest.com
The delivery of drugs through the oral route is regarded as most optimal to achieve desired
therapeutic effects and patient compliance. However, poor pharmacokinetic profiles of oral …

Oral Bioavailability: Issues and Solutions via Nanoformulations.

K Pathak, S Raghuvanshi - Clinical Pharmacokinetics, 2015 - search.ebscohost.com
The delivery of drugs through the oral route is regarded as most optimal to achieve desired
therapeutic effects and patient compliance. However, poor pharmacokinetic profiles of oral …

Oral Bioavailability: Issues and Solutions via Nanoformulations

K Pathak, S Raghuvanshi - Clinical Pharmacokinetics, 2015 - infona.pl
The delivery of drugs through the oral route is regarded as most optimal to achieve desired
therapeutic effects and patient compliance. However, poor pharmacokinetic profiles of oral …

Oral bioavailability: issues and solutions via nanoformulations.

K Pathak, S Raghuvanshi - Clinical Pharmacokinetics, 2015 - europepmc.org
The delivery of drugs through the oral route is regarded as most optimal to achieve desired
therapeutic effects and patient compliance. However, poor pharmacokinetic profiles of oral …

Oral bioavailability: issues and solutions via nanoformulations

K Pathak, S Raghuvanshi - Clinical pharmacokinetics, 2015 - pubmed.ncbi.nlm.nih.gov
The delivery of drugs through the oral route is regarded as most optimal to achieve desired
therapeutic effects and patient compliance. However, poor pharmacokinetic profiles of oral …